Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Behzad Etemad, Ph.D.

Concepts (117)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Behzad Etemad's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Behzad Etemad has written about over time.
Antibodies, Viral, 2 publications between 2006 and 2008, average publication date May 2007. Antigens, Viral, 2 publications between 2006 and 2008, average publication date May 2007. Dengue Virus, 2 publications between 2006 and 2008, average publication date May 2007. Pichia, 1 publications between 2008 and 2008, average publication date August 2008. Viral Envelope Proteins, 4 publications between 2006 and 2013, average publication date July 2009. Receptors, CCR5, 1 publications between 2009 and 2009, average publication date July 2009. Polymerase Chain Reaction, 2 publications between 2009 and 2015, average publication date April 2012. CD4-Positive T-Lymphocytes, 3 publications between 2012 and 2013, average publication date April 2013. CD8-Positive T-Lymphocytes, 2 publications between 2013 and 2013, average publication date November 2013. Integrins, 2 publications between 2013 and 2013, average publication date November 2013. env Gene Products, Human Immunodeficiency Virus, 3 publications between 2013 and 2015, average publication date September 2014. Substance Abuse, Intravenous, 1 publications between 2014 and 2014, average publication date November 2014. Genetic Variation, 2 publications between 2014 and 2015, average publication date January 2015. HIV-1, 11 publications between 2009 and 2021, average publication date August 2015. HIV Infections, 12 publications between 2009 and 2021, average publication date April 2016. Genome, Viral, 2 publications between 2015 and 2018, average publication date November 2016. Withholding Treatment, 3 publications between 2016 and 2021, average publication date January 2019. Proviruses, 2 publications between 2018 and 2021, average publication date January 2020. Anti-Retroviral Agents, 2 publications between 2019 and 2021, average publication date July 2020. Fetal Distress, 1 publications between 2022 and 2022, average publication date February 2022.

To see the data from this visualization as text, click here.
Etemad's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.